Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer

NCT00595972 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00595972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
December 31, 2010
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer